You have 9 free searches left this month | for more free features.

NeuroStar Advanced Therapy System

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Major Depressive Disorder in the UK Using TMS Therapy

Withdrawn
  • Major Depressive Disorder
  • Transcranial Magnetic Stimulator
  • London, United Kingdom
    St Pancras Hospital
Sep 30, 2021

MDD Trial in Tampa (repetitive Transcranial Magnetic Stimulation)

Not yet recruiting
  • Major Depressive Disorder
  • repetitive Transcranial Magnetic Stimulation
  • Tampa, Florida
    TMS of South Tampa
Sep 7, 2022

MDD Trial in Rochester (NeuroStar TMS Therapy® System, NeuroStar XPLOR®)

Active, not recruiting
  • Major Depressive Disorder
  • NeuroStar TMS Therapy® System
  • NeuroStar XPLOR®
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 3, 2023

Depression, Postpartum Trial in United States (NeuroStar Transcranial Magnetic Stimulation (TMS))

Terminated
  • Depression, Postpartum
  • NeuroStar Transcranial Magnetic Stimulation (TMS)
  • Hartford, Connecticut
  • +7 more
Oct 5, 2021

Retrospective TMS Therapy for Adults With MDD

Completed
  • Major Depressive Disorder (MDD)
  • TMS
  • (no location specified)
Sep 12, 2022

Bipolar Depression Trial in Baltimore, Rochester (NeuroStar TMS)

Completed
  • Bipolar Depression
  • NeuroStar TMS
  • Baltimore, Maryland
  • +1 more
May 11, 2022

Cancer in Remission (Any Type or Stage), Depression, Anxiety Trial in Chicago (Repetitive Transcranial Magnetic Stimulation

Active, not recruiting
  • Cancer in Remission (Any Type or Stage)
  • +2 more
  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Chicago, Illinois
    Northwestern University
Jan 11, 2023

Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)

Completed
  • Time in Range
  • Dipeptidyl peptidase-4 inhibitors
  • Cairo, Egypt
    Nancy Elbarbary
Aug 26, 2023

DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

Recruiting
  • Parkinson Disease
  • DiSCERN
  • Cincinnati, Ohio
  • +1 more
Aug 1, 2022

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 24, 2023

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM96 CAR-T cells
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 10, 2022

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Binge Eating, Binge-Eating Disorder, Bulimia Nervosa Trial in Philadelphia (Base self-help CBT program, Just-in-time, adaptive

Recruiting
  • Binge Eating
  • +3 more
  • Base self-help CBT program
  • +2 more
  • Philadelphia, Pennsylvania
    Drexel University
Jul 5, 2023

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Neurologic Disorder Trial in Overland Park (Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics, Standard inpatient

Recruiting
  • Neurologic Disorder
  • Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics
  • Standard inpatient rehabilitation therapy
  • Overland Park, Kansas
    Rehabilitation Hospital of Overland Park
Dec 7, 2022

Advanced or Metastatic Solid Tumor Malignancies Trial in United States (NP-G2-044 Monotherapy, Anti-PD-(L)1 Therapy, NP-G2-044

Recruiting
  • Advanced or Metastatic Solid Tumor Malignancies
  • NP-G2-044 Monotherapy
  • +2 more
  • Scottsdale, Arizona
  • +14 more
Jan 5, 2023

Gastrointestinal Tumors Trial (PTC drug screening)

Not yet recruiting
  • Gastrointestinal Neoplasms
  • PTC drug screening
  • (no location specified)
Mar 4, 2022

Heart Failure Trial in Tokyo (Ventricular Assist Device System)

Active, not recruiting
  • Heart Failure
  • Ventricular Assist Device System
  • Tokyo, Japan
    University of Tokyo
Mar 24, 2022

Uterine Cervical Tumors, Locally Advanced Cervical Carcinoma Trial in Leiden, Rotterdam (External beam radiation therapy:

Recruiting
  • Uterine Cervical Neoplasms
  • Locally Advanced Cervical Carcinoma
  • External beam radiation therapy: IMRT/VMAT
  • +3 more
  • Leiden, Netherlands
  • +1 more
Jun 1, 2022

End-stage Heart Failure Trial in Bron (HeartMate 3 TM Left Ventricular Assist System, Guideline Directed Medical Therapy)

Recruiting
  • End-stage Heart Failure
  • HeartMate 3 TM Left Ventricular Assist System
  • Guideline Directed Medical Therapy
  • Bron, France
    Hôpital Pneumologique et Cardiovasculaire Louis Pradel
May 17, 2022

Advanced Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Copenhagen (CardioMEMS HF System, Standard heart

Not yet recruiting
  • Advanced Heart Failure
  • Heart Failure With Reduced Ejection Fraction
  • CardioMEMS HF System
  • Standard heart failure medical therapy
  • Copenhagen, Denmark
    Rigshospitalet
Mar 18, 2022

Hematopoietic and Lymphoid System Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 29, 2022